Yesterday, the CEO of Medical Transcription Billing (MTBC), Stephen Andrew Snyder, sold shares of MTBC for $136.1K.
Following Stephen Andrew Snyder’s last MTBC Sell transaction on March 28, 2018, the stock climbed by 1.8%.
See today’s analyst top recommended stocks >>
Based on Medical Transcription Billing’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $17.04 million and GAAP net loss of $1.83 million. In comparison, last year the company earned revenue of $7.51 million and had a GAAP net loss of $980.1K. Currently, Medical Transcription Billing has an average volume of 54.43K.
The insider sentiment on Medical Transcription Billing has been neutral according to 37 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.
Stephen Andrew Snyder’s trades have generated a -80.5% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Medical Transcription Billing Corp. is a healthcare information technology company, which engages in the provision of integrated suite of proprietary web-based solutions. Its products and services include electronic health records, practice management, patient engagement, medical billing, value added, consultancy, medical transcription, and business intelligence. The company was founded by Mahmud Ul Haq on September 28, 2001 and is headquartered in Somerset, NY.
